Key facts
- This page summarizes Matthew Pauls's Form 4 filing for SOLENO THERAPEUTICS INC (SLNO).
- 3 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 31 Mar 2025, 19:24.
Matthew Pauls - 28 Mar 2025 Form 4 Insider Report for SOLENO THERAPEUTICS INC (SLNO)
- Reporting relationship
- Director
- Issuer ticker
- SLNO
- Reported as of
- 28 Mar 2025
- Net transaction value
- -$397,487
- SEC form
- 4
- Accepted by SEC
- 31 Mar 2025, 19:24:33 UTC
- Prior SEC filing
- 16 Dec 2024
- Next SEC filing
- 09 Jun 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Anish Bhatnagar, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Matthew Pauls filed Form 4 for SOLENO THERAPEUTICS INC (SLNO) on 31 Mar 2025.
Change
- Previous filing in this sequence was filed on 16 Dec 2024.
- Current net transaction value: -$397,487.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
SLNO
transaction
Common Stock
Options Exercise
- Transaction value
- $27,310
- Shares
- +5,937
- Change %
- +91%
- Price
- $4.60
- Shares after
- 12,437
- Date
- 28 Mar 2025
- Ownership
- Direct
- Footnotes
- F1
SLNO
transaction
Common Stock
Sale
- Transaction value
- $424,797
- Shares
- -5,937
- Change %
- -48%
- Price
- $71.55
- Shares after
- 6,500
- Date
- 28 Mar 2025
- Ownership
- Direct
- Footnotes
- F1, F2
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
SLNO
transaction
Derivative
Employee stock option (right to buy)
Options Exercise
- Transaction value
- $0
- Shares
- -5,937
- Change %
- -40%
- Price
- $0.000000
- Shares after
- 9,063
- Date
- 28 Mar 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 5,937
- Exercise price
- $46.31
- Footnotes
- F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
Certain of these securities are restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Common Stock, subject to the applicable vesting schedule and conditions of each RSU.
Footnote F2
This transaction was executed in multiple trades at prices ranging from $71.54 to $71.69. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
Footnote F3
One forty-eighth (1/48th) of the shares subject to the Option shall vest on September 15, 2023 and each month thereafter on the same day of the month, subject to the Reporting Person continuing to be a Service Provider through each such date.